Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3557)
Xeris Biopharma Holdings, Inc. (XERS)
HALKUFF DAWN — Director
Shares
20,000
Price
$6.09
Total Value
$121.89K
Shares Held After
95,000
% of Holdings
17.4%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
4,104
Price
$34.67
Total Value
$142.29K
Shares Held After
211,930
% of Holdings
1.9%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
25,896
Price
$34.01
Total Value
$880.72K
Shares Held After
216,034
% of Holdings
10.7%
Xeris Biopharma Holdings, Inc. (XERS)
JOHNSON JOHN — Director
Shares
15,000
Price
$6.09
Total Value
$91.42K
Shares Held After
683,083
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$550.46
Total Value
$308.26K
Shares Held After
40,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$549.24
Total Value
$428.41K
Shares Held After
41,073
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,676
Price
$548.26
Total Value
$918.89K
Shares Held After
41,853
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.53
Total Value
$834.98K
Shares Held After
43,529
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$546.14
Total Value
$656.46K
Shares Held After
45,054
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,186
Price
$545.18
Total Value
$646.59K
Shares Held After
46,256
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,470
Price
$544.24
Total Value
$800.04K
Shares Held After
47,442
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
396
Price
$543.11
Total Value
$215.07K
Shares Held After
48,912
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
112
Price
$542.50
Total Value
$60.76K
Shares Held After
49,308
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
473
Price
$541.08
Total Value
$255.93K
Shares Held After
49,420
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$539.51
Total Value
$64.74K
Shares Held After
49,893
% of Holdings
0.2%
Xeris Biopharma Holdings, Inc. (XERS)
BORMANN-KENNEDY BARBARA-JEAN ANNE — Director
Shares
16,000
Price
$6.09
Total Value
$97.51K
Shares Held After
126,500
% of Holdings
11.2%
Equillium, Inc. (EQ)
Connelly Stephen — President and CSO
Shares
200,000
Price
$3.16
Total Value
$632.76K
Shares Held After
793,000
% of Holdings
20.1%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
23,033
Price
$7.18
Total Value
$165.31K
Shares Held After
2,827,788
% of Holdings
0.8%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,898
Price
$4.41
Total Value
$17.19K
Shares Held After
175,288
% of Holdings
2.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$9.31
Total Value
$465.29K
Shares Held After
936,000
% of Holdings
5.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$9.31
Total Value
$465.29K
Shares Held After
936,000
% of Holdings
5.3%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
138,051
Price
$50.12
Total Value
$6.92M
Shares Held After
440,494
% of Holdings
23.9%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
1,961
Price
$50.09
Total Value
$98.23K
Shares Held After
173,280
% of Holdings
1.1%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
1,600
Price
$49.28
Total Value
$78.85K
Shares Held After
175,241
% of Holdings
0.9%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
1,776
Price
$50.12
Total Value
$89.01K
Shares Held After
137,240
% of Holdings
1.3%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
1,400
Price
$49.31
Total Value
$69.03K
Shares Held After
139,016
% of Holdings
1.0%
VERACYTE, INC. (VCYT)
Leite John — Global Chief Commercial Off
Shares
13,975
Price
$50.07
Total Value
$699.73K
Shares Held After
132,305
% of Holdings
9.6%
Summit Therapeutics Inc. (SMMT)
DUGGAN ROBERT W — Director
Shares
100,000
Price
$14.60
Total Value
$1.46M
Shares Held After
25,824,474
% of Holdings
0.4%
Summit Therapeutics Inc. (SMMT)
Zanganeh Mahkam — Director
Shares
100,000
Price
$14.60
Total Value
$1.46M
Shares Held After
25,824,474
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,250
Price
$549.47
Total Value
$686.84K
Shares Held After
45,172
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
593
Price
$549.49
Total Value
$325.85K
Shares Held After
46,422
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,481
Price
$548.42
Total Value
$812.22K
Shares Held After
47,015
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
935
Price
$547.11
Total Value
$511.55K
Shares Held After
48,496
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,627
Price
$546.42
Total Value
$1.44M
Shares Held After
49,431
% of Holdings
5.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
374
Price
$545.27
Total Value
$203.93K
Shares Held After
52,058
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
840
Price
$543.89
Total Value
$456.87K
Shares Held After
52,432
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$539.76
Total Value
$107.95K
Shares Held After
53,272
% of Holdings
0.4%
Summit Therapeutics Inc. (SMMT)
Soni Manmeet Singh — Director
Shares
25,000
Price
$14.43
Total Value
$360.75K
Shares Held After
3,123,603
% of Holdings
0.8%
Summit Therapeutics Inc. (SMMT)
Soni Manmeet Singh — Director
Shares
25,000
Price
$14.46
Total Value
$361.50K
Shares Held After
3,098,603
% of Holdings
0.8%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$43.05
Total Value
$87.56K
Shares Held After
229,524
% of Holdings
0.9%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
714
Price
$1.55
Total Value
$1.11K
Shares Held After
63,890
% of Holdings
1.1%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
7,069
Price
$1.55
Total Value
$10.96K
Shares Held After
632,835
% of Holdings
1.1%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
5,500
Price
$78.71
Total Value
$432.90K
Shares Held After
205,648
% of Holdings
2.6%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,500
Price
$17.48
Total Value
$43.70K
Shares Held After
22,500
% of Holdings
11.1%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,000
Price
$2.13
Total Value
$4.26K
Shares Held After
7,779
% of Holdings
25.7%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
2,566
Price
$102.27
Total Value
$262.42K
Shares Held After
62,344
% of Holdings
4.0%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
2,404
Price
$102.27
Total Value
$245.86K
Shares Held After
69,082
% of Holdings
3.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
7,605
Price
$102.27
Total Value
$777.76K
Shares Held After
265,432
% of Holdings
2.8%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
2,159
Price
$102.27
Total Value
$220.80K
Shares Held After
39,454
% of Holdings
5.2%
Aldeyra Therapeutics, Inc. (ALDX)
Brady Todd C — Director
Shares
250,000
Price
$1.67
Total Value
$418.45K
Shares Held After
1,721,298
% of Holdings
14.5%
Showing 301–350 of 3557 transactions (page 7 of 72)